The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection

Virology Journal

Volumn 7, Issue , 2010, Pages

  Mohamadkhani, Ashraf ^a   Sayemiri, Kourosh ^b   Ghanbari, Reza ^a   Elahi, Elham ^a   Poustchi, Hossein ^a   Montazeri, Ghodratollah ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN; LIPID; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; ADIPONECTIN, HUMAN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CORRELATION ANALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERSISTENT VIRUS INFECTION; BLOOD; CHEMISTRY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SERUM; VIROLOGY; VIRUS REPLICATION;

HEPATITIS B VIRUS;

ADIPONECTIN; ADULT; ALANINE TRANSAMINASE; DNA, VIRAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; SERUM; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 77956468283     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-228     Document Type: Article

References (31)

1. Hepatitis B: an important public health issue. WC Maddrey, J Med Virol 2000 61 362 366 10.1002/1096-9071(200007)61:3<362::AID-JMV14>3.0.CO;2-I 10861647
2. Evaluation of redox statuses in patients with hepatitis B virus-associated hepatocellular carcinoma. SM Tsai SK Lin KT Lee JK Hsiao JC Huang SH Wu H Ma LY Tsai, Ann Clin Biochem 2009 46 394 400 10.1258/acb.2009. 009029 19641006
3. The role of mutations in core protein of hepatitis B virus in liver fibrosis. A Mohamadkhani FR Jazii H Poustchi O Nouraein S Abbasi M Sotoudeh G Montazeri, Virol J 2009 6 209 10.1186/1743-422X-6-209 19939285
4. Genetic susceptibility in chronic viral hepatitis. M Thursz, Antiviral Res 2001 52 113 116 10.1016/S0166-3542(01)00175-9 11672820
5. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. A Kontush MJ Chapman, Pharmacol Rev 2006 58 342 374 10.1124/pr.58.3.1 16968945
6. High-density lipoprotein: why all the fuss? B Mackness M Mackness, Ann Clin Biochem 2009 46 5 7 10.1258/acb.2008.008133 19015220
7. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. T Masaki S Chiba H Tatsukawa T Yasuda H Noguchi M Seike H Yoshimatsu, Hepatology 2004 40 177 184 10.1002/hep.20282 15239101
8. High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells. GD Norata E Callegari M Marchesi G Chiesa P Eriksson AL Catapano, Circulation 2005 111 2805 2811 10.1161/CIRCULATIONAHA.104. 472886 15911702
9. Serum adiponectin in chronic hepatitis C and B. D Siagris G Vafiadis M Michalaki A Lekkou I Starakis M Makri V Margaritis M Christofidou AC Tsamandas C Labropoulou-Karatza, J Viral Hepat 2007 14 577 583 10.1111/j.1365-2893.2007. 00850.x 17650292
10. Chronic hepatitis B virus infection and dyslipidemia. TC Su YT Lee TJ Cheng HP Chien JD Wang, J Formos Med Assoc 2004 103 286 291 15175824
11. The evolving role of leptin and adiponectin in chronic liver diseases. E Tsochatzis GV Papatheodoridis AJ Archimandritis, Am J Gastroenterol 2006 101 2629 2640 16952281
12. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people. Y Hui L Yu-Yuan N Yu-Qiang S Wei-Hong D Yan-Lei L Xiao-Bo Z Yong-Jian, Liver Int 2008 28 385 392 10.1111/j.1478-3231.2007.01623.x 17999673
13. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. T Yamauchi J Kamon Y Ito A Tsuchida T Yokomizo S Kita T Sugiyama M Miyagishi K Hara M Tsunoda, et al. Nature 2003 423 762 769 10.1038/nature01705 12802337
14. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. A Xu Y Wang H Keshaw LY Xu KS Lam GJ Cooper, J Clin Invest 2003 112 91 100 12840063
15. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. M You RV Considine TC Leone DP Kelly DW Crabb, Hepatology 2005 42 568 577 10.1002/hep.20821 16108051
16. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. World Health Organization Press; Department of Noncommunicable Disease Surveillance. Geneva. KGMM Alberti ACD Aschner PH Bennett NIDDK Phoenix, et al. 1999
17. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. CJ Chen HI Yang UH Iloeje, Hepatology 2009 49 72 84 10.1002/hep.22884 19399801
18. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. CJ Chen HI Yang J Su CL Jen SL You SN Lu GT Huang UH Iloeje, JAMA 2006 295 65 73 10.1001/jama.295.1.65 16391218
19. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. UH Iloeje HI Yang J Su CL Jen SL You CJ Chen, Gastroenterology 2006 130 678 686 10.1053/j.gastro.2005.11.016 16530509
20. High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation? D Burger JM Dayer, Autoimmun Rev 2002 1 111 117 10.1016/S1568-9972(01)00018-0 12849067
21. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. M Navab JA Berliner G Subbanagounder S Hama AJ Lusis LW Castellani S Reddy D Shih W Shi AD Watson, et al. Arterioscler Thromb Vasc Biol 2001 21 481 488 11304461
22. High-density lipoprotein cholesterol in HIV-infected patients: evidence for an association with HIV-1 viral load, antiretroviral therapy status, and regimen composition. E Bernal M Masia S Padilla F Gutierrez, AIDS Patient Care STDS 2008 22 569 575 10.1089/apc.2007.0186 18479224
23. High-density lipoprotein concentrations relate to the clinical course of HIV viral load in patients undergoing antiretroviral therapy. C Alonso-Villaverde T Segues B Coll-Crespo R Perez-Bernalte A Rabassa M Gomila S Parra MA Gozalez-Esteban MJ Jimenez-Exposito L Masana, AIDS 2003 17 1173 1178 10.1097/00002030-200305230-00009 12819519
24. Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy. CS Hsu CH Liu CJ Liu CL Chen MY Lai PJ Chen DS Chen JH Kao, Antivir Ther 2009 14 45 54 19320236
25. Blood lipids of patients with chronic hepatitis: differences related to viral etiology. C Fabris E Federico G Soardo E Falleti M Pirisi, Clin Chim Acta 1997 261 159 165 10.1016/S0009-8981(97)06532-7 9201435
26. High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats. D Thabut KA Tazi D Bonnefont-Rousselot M Aller O Farges MC Guimont Z Tellier C Guichard E Ogier-Denis T Poynard, et al. Hepatology 2007 46 1893 1906 10.1002/hep.21875 17918268
27. [Trypanolytic factor of human serum]. D Perez-Morga, Bull Mem Acad R Med Belg 2006 161 309 315 17283903
28. Neutrophil association and degradation of normal and acute-phase high-density lipoprotein 3. EG Shephard FC de Beer MC de Beer MS Jeenah GA Coetzee DR van der Westhuyzen, Biochem J 1987 248 919 926 2449174
29. Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. CK Hui HY Zhang NP Lee W Chan YH Yueng KW Leung L Lu N Leung CM Lo ST Fan, et al. J Hepatol 2007 47 191 202 10.1016/j.jhep.2007.02.023 17462782
30. Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. WH Ettinger VK Varma M Sorci-Thomas JS Parks RC Sigmon TK Smith RB Verdery, Arterioscler Thromb 1994 14 8 13 8274481
31. Comparison of bioelectrical impedance and BMI in predicting obesity-related medical conditions. K Willett R Jiang E Lenart D Spiegelman W Willett, Obesity (Silver Spring) 2006 14 480 490 10.1038/oby.2006.63 16648620